000 01650 a2200493 4500
005 20250514220254.0
264 0 _c20050707
008 200507s 0 0 eng d
022 _a1462-0324
024 7 _a10.1093/rheumatology/keh575
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBodolay, E
245 0 0 _aEvaluation of interstitial lung disease in mixed connective tissue disease (MCTD).
_h[electronic resource]
260 _bRheumatology (Oxford, England)
_cMay 2005
300 _a656-61 p.
_bdigital
500 _aPublication Type: Comparative Study; Evaluation Study; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aCyclophosphamide
_xtherapeutic use
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aGlucocorticoids
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLung Diseases, Interstitial
_xdiagnosis
650 0 4 _aMale
650 0 4 _aMethylprednisolone
_xtherapeutic use
650 0 4 _aMiddle Aged
650 0 4 _aMixed Connective Tissue Disease
_xcomplications
650 0 4 _aRadionuclide Imaging
650 0 4 _aRadiopharmaceuticals
650 0 4 _aRespiratory Function Tests
650 0 4 _aRetrospective Studies
650 0 4 _aTechnetium Tc 99m Pentetate
650 0 4 _aTomography, X-Ray Computed
700 1 _aSzekanecz, Z
700 1 _aDévényi, K
700 1 _aGaluska, L
700 1 _aCsípo, I
700 1 _aVègh, J
700 1 _aGarai, I
700 1 _aSzegedi, G
773 0 _tRheumatology (Oxford, England)
_gvol. 44
_gno. 5
_gp. 656-61
856 4 0 _uhttps://doi.org/10.1093/rheumatology/keh575
_zAvailable from publisher's website
999 _c15391911
_d15391911